PGF and cancer: Particularly, it has been demonstrated that engineering therapeutic proteins with the ECM-binding motif from PlGF increases the efficacy of the drug at low doses not only in the context of regenerative medicine applications8,15,16, but also in other settings such as cancer immunotherapy38,39.